Servier Bio-innovation Llc
Clinical trials sponsored by Servier Bio-innovation Llc, explained in plain language.
-
New study checks cancer drug safety for patients with organ issues
Disease control Recruiting nowThis study tests the safety and how the body processes the drug ivosidenib in 30 adults with IDH1-mutated cancers who also have liver or kidney problems. Participants take the drug by mouth and have regular checkups including blood tests and heart monitoring. The goal is to find …
Phase: PHASE1 • Sponsor: Servier Bio-Innovation LLC • Aim: Disease control
Last updated May 17, 2026 04:37 UTC
-
New pill targets Hard-to-Treat cancers with missing MTAP gene
Disease control Recruiting nowThis study tests a new oral drug called S095035, alone or with another drug (TNG462), in adults with advanced solid tumors that have a specific gene deletion (MTAP). These cancers have not responded to at least one prior treatment. The goal is to see if the drug is safe and can s…
Phase: PHASE1, PHASE2 • Sponsor: Servier Bio-Innovation LLC • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New hope for rare bone cancer: targeted pill slows tumor growth
Disease control Recruiting nowThis study tests an oral drug called ivosidenib in adults with a rare bone cancer (chondrosarcoma) that has spread and has a specific gene change (IDH1 mutation). About 136 participants will receive either the drug or a placebo to see if it delays cancer progression. The goal is …
Phase: PHASE3 • Sponsor: Servier Bio-Innovation LLC • Aim: Disease control
Last updated May 15, 2026 11:53 UTC